The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Calls for Proposals

EDCTP opened new calls for research proposals under its second programme: diagnostic tools for poverty-related diseases; maximising the impact of EDCTP research; strategic projects with major cofunding; improved treatment; and clinical management of poverty-related diseases.

Read more

About us

EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 14 African and 14 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.

Find out more about who we are!

Read more

Scope

EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.

Read more

Latest news

21 December 2015

Farewell Letter from Charles Mgone, EDCTP Executive Director

After almost a decade at the European & Developing Countries Clinical Trials Partnership (EDCTP), it is an appropriate time for…

Read more
9 December 2015

EDCTP receives Science Diplomacy Award at South African Science Forum

At the Science Forum South Africa 2015, EDCTP received the Science Diplomacy Award in the category that recognises “an international…

Read more